CDMO & custom formulation
Bring us the brief, not the formula
Full development: we design the formulation around the mechanism you are targeting, prove it survives, scale it and supply it.
This is the service for a product that does not exist yet, or one that exists and does not work. You bring the therapeutic intent and the market; we bring the formulation science, the stability programme and the plant. You own the resulting formula.
This is the right service if
- Your active is poorly soluble, unstable, or has failed to show effect in a previous formulation.
- You need claims that rest on evidence you can cite, rather than category convention.
- You want to own the formula and the regulatory file at the end of it.
CDMO & custom formulation
How a project runs
- 01
Technical call and NDA
We establish what the product must do, in which market, at what volume. An NDA is signed before any technical detail is exchanged.
- 02
Formulation design
Delivery system, excipient matrix and dose are selected against the mechanism and the bioavailability constraint. You get a rationale, not just a specification.
- 03
Prototype and stability
Pilot batches are manufactured and placed on accelerated stability. Where absorption is the risk, we design the strategy to address it explicitly.
- 04
Scale-up and validation
The process moves to commercial scale with parameters validated at that scale, not extrapolated from the bench.
- 05
Registration and supply
We prepare the development and quality sections of your dossier, then supply to forecast with full batch documentation.
Bring us the formulation that has not worked yet.
Tell us the mechanism you are targeting and the market you are selling into. We will tell you honestly whether we can engineer it, and what it will take.